Campbell Newman Asset Management Inc Corcept Therapeutics Inc Transaction History
Campbell Newman Asset Management Inc
- $1.19 Billion
- Q2 2025
A detailed history of Campbell Newman Asset Management Inc transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Campbell Newman Asset Management Inc holds 35,360 shares of CORT stock, worth $2.56 Million. This represents 0.22% of its overall portfolio holdings.
Number of Shares
35,360
Previous 32,985
7.2%
Holding current value
$2.56 Million
Previous $3.77 Million
31.11%
% of portfolio
0.22%
Previous 0.34%
Shares
28 transactions
Others Institutions Holding CORT
# of Institutions
469Shares Held
83.4MCall Options Held
1.42MPut Options Held
2.75M-
Black Rock Inc. New York, NY16.5MShares$1.2 Billion0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.98MShares$722 Million0.02% of portfolio
-
Ingalls & Snyder LLC New York, NY7.72MShares$558 Million20.11% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.14MShares$444 Million1.13% of portfolio
-
Parallel Advisors, LLC3.87MShares$280 Million5.83% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $7.74B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...